In the Biocarta enrichment analysis, the low-risk gene set was functionally associated with endogenous thrombospondin activation, lipid metabolism and toxic nuclear receptors, and complement pathways; the high-risk genes were relevant to cell cycle regulation, BRCA1/2, and ATR susceptibility in cancer (Figure 6A). This evidence concerns the gene BRCA1 and cancer.